Identification of low oxygen-tolerating bacteria in prostate secretions of cancer patients and discussion of possible aetiological significance
Roshni Bhudia(Queen Mary University of London), R.T.D. Oliver(University of Cambridge), Mark Wilks(Queen Mary University of London), Amar Ahmad(Cancer Research UK), Onyinye Akpenyi, Angela Whiley(Queen Mary University of London)
Cited by 7
Related Papers
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
|The Lancet|2005|447
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|Journal of Clinical Oncology|1997|334
Cancer incidence in the United Kingdom: projections to the year 2030
|British Journal of Cancer|2011|285
Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960
|British Journal of Cancer|2015|275